FDA Inspection
Department of Defense - ArmyDepartment of Defense - Army – FDA Inspection, Feb 10, 2012
Record Details
This FDA Inspection record concerns Department of Defense - Army, with an inspection on February 10, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Department of Defense - Army
- Inspection Date
- February 10, 2012
- Product Type
- Biologics
View Company Profile
ID · fce04814-e6e2-466f-a0b1-883af7471859
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 768762
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
3- 21 CFR 606.40(b)Adequate lighting, ventilation, and screening
- 21 CFR 606.40(a)(1)Provide space for examination
- 21 CFR 606.40Suitable size, construction, etc.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Department of Defense - Army
5| Date | Classification | Office | Project area |
|---|---|---|---|
| May 9, 2025 | VAI | Atlanta District Office | Blood and Blood Products |
| March 24, 2023 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| August 26, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 28, 2014 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 12, 2010 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Department of Defense - Army
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.